微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 33.35% | 3.83% | 0.41% | 103/129 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 33.22% | 3.26% | 0.24% | 103/129 | 53.65% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 33.14% | -4.94% | 1.49% | 99/129 | 53.62% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 32.65% | -17.33% | 1.65% | 102/129 | 53.85% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 32.12% | -21.84% | -0.14% | 102/129 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 32.17% | -24.16% | -7.72% | 104/129 | 53.61% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 34.86% | -22.62% | -11.75% | 96/129 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 39.5% | -10.95% | -3.89% | 94/129 | 54.04% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 41.1% | -13.26% | -3.11% | 88/129 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 42.42% | -11.65% | -5.84% | 87/129 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 45.05% | -9.83% | 1.56% | 77/129 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 44.36% | -6.04% | -6.38% | 92/129 | 57.38% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 47.38% | -2.79% | -1.31% | 76/129 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 48.01% | -0.53% | -3.91% | 82/129 | 58.42% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 49.96% | 2% | 5.84% | 71/129 | 60.75% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 47.21% | 6.28% | -3.15% | 90/129 | 59.67% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 48.74% | 2% | 0.98% | 66/129 | 61.59% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 48.27% | 9.49% | 8.67% | 82/129 | 59.94% | 正海生物 | 92.61% | 行业排名> |
| 2019-12-31 | 44.42% | 8.74% | 0.75% | 82/129 | 56.37% | 正海生物 | 94.38% | 行业排名> |
| 2019-06-30 | 44.08% | 2% | 7.93% | 51/129 | 57.37% | 正海生物 | 93.12% | 行业排名> |
| 2018-12-31 | 40.84% | -2.39% | -2.39% | 77/129 | 55.53% | 正海生物 | 93.78% | 行业排名> |
| 2017-12-31 | 41.84% | 2% | 2% | 71/129 | 55.34% | 正海生物 | 93.09% | 行业排名> |